Home/Pipeline/SCO-267

SCO-267

Diabetes, Obesity, MASH

PreclinicalActive

Key Facts

Indication
Diabetes, Obesity, MASH
Phase
Preclinical
Status
Active
Company

About SCOHIA PHARMA

A Japanese bioventure developing innovative small molecule drugs for metabolic, cardiovascular, and renal diseases through a diversified pipeline and strategic collaborations.

View full company profile